Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: Editorial [Hot Topic: Recent Developments and Future Directions in the Treatment of Systemic Rheumatic Diseases (Guest Editor: Minoru Satoh) ]
Volume: 6 Issue: 4
Author(s): Minoru Satoh
Affiliation:
Export Options
About this article
Cite this article as:
Satoh Minoru, Editorial [Hot Topic: Recent Developments and Future Directions in the Treatment of Systemic Rheumatic Diseases (Guest Editor: Minoru Satoh) ], Endocrine, Metabolic & Immune Disorders - Drug Targets 2006; 6 (4) . https://dx.doi.org/10.2174/187153006779025784
DOI https://dx.doi.org/10.2174/187153006779025784 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Potential Therapeutic Value of Renin-Angiotensin System Inhibitors in the
Treatment of Colorectal Cancer
Current Pharmaceutical Design Applied Computational Techniques on Schizophrenia Using Genetic Mutations
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Endoplasmic Reticulum Stress and Mitochondrial Dysfunction in Diseases: Molecular Targets)
Current Pharmaceutical Design Editorial (Thematic Issue: Medicinal Chemistry: Neurological and Endocrinological Disorders)
Medicinal Chemistry Peptide Therapeutics in Neurodegenerative Disorders
Current Medicinal Chemistry Design and Synthesis of Novel 1,3,4-Oxadiazole Derivatives Bearing Azo Moiety as Biologically Significant Scaffolds
Letters in Drug Design & Discovery Urtica dioica Extract Inhibits Cell Proliferation and Induces Apoptosis in HepG2 and HTC116 as Gastrointestinal Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Leptin Transport Across the Blood-Brain Barrier: Implications for the Cause and Treatment of Obesity
Current Pharmaceutical Design Bisphosphonates and Breast Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Late versus Early Onset Depression in Elderly Patients: Vascular Risk and Cognitive Impairment
Current Aging Science Discovery of JANUVIA <sup>TM</sup> (Sitagliptin), a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type2 Diabetes.
Current Topics in Medicinal Chemistry Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting
Recent Patents on Nanotechnology Clinical Patterns of Primary Biliary Cholangitis: Comparison Between Two European Case Series
Reviews on Recent Clinical Trials Patent Selections:
Recent Patents on Biotechnology α-(-)-bisabolol Reduces Pro-inflammatory Cytokine Production and Ameliorates Skin Inflammation
Current Pharmaceutical Biotechnology Periodontal Disease and Potential Association with Systemic Diseases and Conditions (Mini-review)
Applied Clinical Research, Clinical Trials and Regulatory Affairs Flavonoids and Related Compounds in Non-Alcoholic Fatty Liver Disease Therapy
Current Medicinal Chemistry Novel Approaches in the Treatment of Antipsychotic-Induced Hyperprolactinemia: The Role of Partial Agonists of D2 Dopaminergic Receptors
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Levamisole-Induced Leukoencephalopathy in Russia: Analysis of 30 Cases
Current Drug Safety Integrins in Bone Metastasis Formation and Potential Therapeutic Implications
Current Cancer Drug Targets